AMGN : Analysis & Opinions

  • Showing 101-124 of 124 items
  • <<
  • 1
  • 2
  1. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  2. Amgen and Other Healthcare Stocks Making Big Moves on October ...

    October 19, 2012
    The market is having a bad day so far: the Nasdaq has slipped 1.6%; the S&P 500 is trading down 1%; and the Dow is down ...
  3. It's Time to Sell These 4 Surging Stocks

    October 19, 2012
    With the S&P 500 surging roughly 25% in the past 12 months, it's been a great time to have full exposure to the stock ...
  4. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally.
  5. 5 Familiar Stocks to Sell (or Short)! - Investment Ideas

    August 3, 2012
    Like so many people around the planet, I tuned into some Olympic action over the weekend. Ever since childhood, I have enjoyed ...
  6. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take profits on ...
  7. Healthcare Stocks Continuing To Outperform

    July 18, 2012
    These healthcare stocks are still on fire, with potentially more upside left. But is that actually bad for the stock market?
  8. DaVita to Settle Epogen Lawsuit - Analyst Blog

    July 6, 2012
    Recently, DaVita Inc. (DVA) agreed to pay $55 million in a bid to settle a lawsuit, indicting it for overuse of Amgen Inc's ...
  9. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

    May 22, 2012
    Agilent is paying up to get into the increasingly crowded diagnostics market.
  10. Biotech ETFs Hitting Highs

    May 17, 2012
    Biotech ETFs are hitting all-time highs and XBI looks like the best of the group. Because the ETF is already up 25% in 2 ...
  11. AstraZeneca Searches For Answers

    May 3, 2012
    AstraZeneca has an opportunity to do something big when it brings in a new CEO.
  12. 4 ETFs On Fire Right Now

    February 3, 2012
    The commodities market had some of the best-performing ETFs of January.
  13. Big Buys In Share Buybacks

    January 27, 2012
    Record corporate profits and super low interest rates are resulting in a shrinking market environment and a rise in share ...
  14. Be Your Own Venture Capitalist With These Stocks

    September 16, 2011
    By doing some digging, there are ways for the average joe to become his/her own venture capital fund.
  15. A Deal At Last For Sanofi And Genzyme

    February 18, 2011
    Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
  16. Top-Heavy Pharmaceuticals

    August 27, 2010
    Investors should keep an eye on how much drug companies rely on its top sellers.
  17. Getting In On Growth At A Great Price

    July 5, 2010
    Here are some growth-oriented stocks with below-market average P/Es that investors can pick up during this shaky market to ...
  18. Biotech Bargains

    June 17, 2010
    High-growth biotech stocks are now priced like value plays.
  19. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others.
  20. Two More Reasons To Diversify

    June 3, 2009
    GM and Citigroup being removed from the DJIA should cause investors to focus on diversification.
  21. Convertible Securities In Today's Market

    April 30, 2009
    John Calamos, the father of convertible investing, moderated a panel on convertible bonds at the Milken Global Conference ...
  22. Dark Horse Candidates To Enter The Dow

    March 4, 2009
    The DJIA is sure to be rebalanced over the next year as some members teeter on bankruptcy or face falling from the index.
  23. Buyer Beware In Biotech ETFs

    August 27, 2007
    The biotech sector has been flat this year, and the five biotech ETFs have been hit and miss - mainly miss.
  24. Up on Amgen (AMGN)

    April 30, 2007
    Amgen shares are in a rut, and that could signal opportunity for investors.
  • Showing 101-124 of 124 items
  • <<
  • 1
  • 2
Trading Center